PRVA

Business Context and Reporting Period

Company: Privia Health Group, Inc. (PRVA)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Year ended December 31, 2025
Business Overview: Privia Health is a technology-driven, national physician-enablement company that organizes physicians into Medical Groups to transition from fee-for-service (FFS) to value-based care (VBC) models. The company operates in 16 markets across 24 states and the District of Columbia, utilizing a cloud-based technology platform to manage care delivery, revenue cycle, and population health.

Key Financial Metrics

Key Non-GAAP Metrics:
- Practice Collections: $3.47 billion (2025) vs. $2.97 billion (2024).
- Care Margin: $462.2 million (2025) vs. $403.9 million (2024).
- Platform Contribution: $234.8 million (2025) vs. $195.6 million (2024).
- Implemented Providers: 5,380 (2025) vs. 4,789 (2024).
- Attributed Lives: 1.54 million (2025) vs. 1.26 million (2024).

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 22.3% year-over-year to $2.12 billion, driven by organic growth and acquisitions. FFS-patient care revenue grew 18.7%, while capitated revenue surged 44.8% due to increased attributed lives and improved contract terms.
• Profitability: Operating income more than doubled to $34.2 million (101.6% increase), and Net Income attributable to Privia increased 59.3% to $22.9 million.
• Acquisitions: Significant M&A activity in 2025 included the acquisition of a majority interest in Privia Medical Group Arizona (PMG AZ) in April and the acquisition of Evolent Health, Inc.'s accountable care business in December, adding over 120,000 attributed lives.
• Expense Trends: Provider expenses increased 24.6% to $1.66 billion, reflecting higher FFS revenue and provider growth. Cost of platform increased 11.3% to $252.7 million, driven by salaries, stock-based compensation, and professional services.
• Cash Flow: Net cash provided by operating activities increased to $163.4 million from $109.3 million. Net cash used in investing activities was $181.6 million, primarily due to business acquisitions.

Guidance, Outlook, and Risks

Management Commentary & Outlook:
Management emphasizes a strategy of transitioning markets from FFS to VBC to drive sustainable growth. The company expects continued growth in attributed lives and provider base through organic expansion and strategic acquisitions. The focus remains on improving per-patient revenue economics and managing total cost of care to enhance shared savings and capitated margins.

Key Risks and Contingencies:
- Regulatory Compliance: Heavy reliance on federal and state healthcare laws (Stark Law, Anti-Kickback Statute, HIPAA). Non-compliance could result in penalties, exclusion from government programs, or reputational harm.
- Reimbursement Risk: Revenue is dependent on third-party payer contracts. Changes in reimbursement rates, payer mix, or contract terms (e.g., Medicare Advantage risk adjustment models) could materially impact financial results.
- Value-Based Care (VBC) Performance: VBC revenues are subject to performance targets regarding cost of care and quality metrics. Failure to meet these targets could result in reduced revenue or downside risk payments.
- Cybersecurity: The company faces risks related to data breaches and cybersecurity incidents, which could disrupt operations and incur significant remediation costs.
- Vendor Dependency: Reliance on athenahealth, Inc. for the Electronic Medical Record (EMR) system creates operational risk if the relationship is disrupted.

Investor Verification Checklist

• Acquisition Integration: Verify the financial performance and integration progress of the Arizona and Evolent Health acquisitions, which contributed significantly to 2025 growth.
• VBC Contract Terms: Review the specific terms of "at-risk" capitated contracts and the exposure to downside risk in Medicare Advantage and commercial programs.
• Provider Retention: Confirm the 96% provider retention rate cited by management and assess any attrition trends in new markets.
• Regulatory Audits: Monitor for any ongoing or new government audits (CMS, OIG) related to risk adjustment coding (RAF scores) and shared savings calculations.
• Stock-Based Compensation: Note the significant increase in stock-based compensation expense ($71.1 million in 2025 vs. $56.7 million in 2024) and its impact on future cash flow and dilution.